BRCA1突变携带者预防性输卵管切除后仍发生卵巢癌
本文报告一例BRCA1突变女性在40岁前接受预防性乳房切除及双侧输卵管切除保留卵巢,未行卵巢切除,术后4年发生IV期高级别浆液性卵巢癌。作者指出,预防性输卵管切除在该高危人群中的有效性证据有限,需进一步研究其作用、延迟卵巢切除的时机及与 upfront 降低风险输卵管卵巢切除的风险获益比较。
要点
- BRCA1/2突变女性终身卵巢癌风险高达46%。
- 预防性输卵管切除后仍可发生高级别浆液性卵巢癌。
- 该高危人群预防性输卵管切除的有效性证据有限。
核心结论
- BRCA1突变女性预防性输卵管切除保留卵巢后仍可能发生IV期高级别浆液性卵巢癌。
- 需更多研究明确预防性输卵管切除联合延迟卵巢切除的作用及最佳完成卵巢切除时机。
研究设计与样本
- 个案报告:一例BRCA1突变女性,40岁前接受预防性乳房切除及双侧输卵管切除保留卵巢,未行卵巢切除。
主要发现
- 该患者在初始手术后4年发生IV期高级别浆液性卵巢癌。
- BRCA1/2突变女性终身卵巢癌风险高达46%。
临床怎么用
- 对BRCA1突变女性,预防性输卵管切除保留卵巢后仍需警惕卵巢癌发生。
- 预防性输卵管切除联合延迟卵巢切除的时机与风险获益需个体化评估。
局限性
- 个案报告,证据级别有限,不能推广至所有BRCA1突变携带者。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Women with germline BRCA1 or BRCA2 mutations have a lifetime risk of ovarian cancer of up to 46%. Opportunistic salpingectomy has been advocated as a risk-reducing strategy owing to increasing recognition of tubal origin, yet evidence of efficacy in this high-risk population is limited. CASE: This is the case of a woman with a BRCA1 mutation who underwent prophylactic mastectomy and bilateral salpingectomy with ovarian retention before the age of 40 years. She did not undergo oophorectomy and subsequently developed stage IV high-grade serous ovarian cancer 4 years after her initial surgery. CONCLUSION: More research is needed to determine the role of prophylactic salpingectomy with delayed oophorectomy, optimal timing of completion oophorectomy, and the risks and benefits compared with up-front risk-reducing salpingo-oophorectomy.
引用
- Lugo Santiago N, Smith E, Cox M, et al. Ovarian Cancer After Prophylactic Salpingectomy in a Patient With Germline BRCA1 Mutation. Obstet Gynecol. 2020. PMID: 32459417. doi:10.1097/AOG.0000000000003864
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。